PGE2 is a potent antilipolytic agent produced by adipose tissue, but its role as a physiological regulator of triglyceride lipolysis is controversial because inhibitors of prostaglandin synthesis have not enhanced hormone-stimulated lipolysis in adipose tissue consistently. Adipose tissue also produces PGI2, but this eicosanoid has not had a demonstrated effect on lipolysis under physiological conditions previously. We investigated both PGE2 and PGI2 production and their effects on lipolysis in rat adipose tissue. We found that 1) EPI-stimulated PGE2 production (like PGI2 production) requires the cooperation of adipocytes and endothellal cells, 2) adipose tissue produces PGE2 and PGI2 at comparable rates, 3) indomethacin inhibits EPI-induced PGE2 and PGI2 production and has no effect on EPI-stimulated lipolysis when added to a mixture of adipocytes and endothelial cells or to intact epididymal fat pads, 4) PGI2 is a potent lipolytic agent when added to isolated adipocytes in the absence of endothelial cells under physiological conditions, 5) the magnitudes and the ED50s of the antllipolytic effect of PGE2 and the lipolytic effect of PGI2 in isolated adipocytes in the absence of endothelial cells are comparable, 6) PGI2 antagonizes the antllipolytic effect of PGE2 in isolated adipocytes in the absence of endothelial cells in a dosage-related manner, and 7) the antllipolytic effect of added PGE2 in isolated adipocytes is greater in the absence of endothelial cells than in their presence, suggesting that endogenous eicosanoid production reduces the effectiveness of added PGE2. These studies demonstrate that catecholamine-induced lipolysis is under the coordinate control of PGE2, a potent antllipolytic agent, and PGI2, a potent lipolytic agent. The failure of PGH synthase inhibition to affect lipolysis can be explained by concurrent PGE2 and PGI2 inhibition. The existence of this mechanism for coordinate control of lipolysis may have broad implications for the function of adipose tissue in health and disease.
Skip Nav Destination
Article navigation
Original Articles|
August 01 1992
Coordinate Control of Lipolysis by Prostaglandin E2 and Prostacyclin in Rat Adipose Tissue
Katina Chatzipanteli;
Katina Chatzipanteli
Diabetes Unit, Massachusetts General Hospital
Boston, Massachusetts
Search for other works by this author on:
Sheila Rudolph;
Sheila Rudolph
Diabetes Unit, Massachusetts General Hospital
Boston, Massachusetts
Search for other works by this author on:
Lloyd Axelrod
Lloyd Axelrod
Diabetes Unit, Massachusetts General Hospital
Boston, Massachusetts
Search for other works by this author on:
Address correspondence and reprint requests to Lloyd Axelrod, MD, Diabetes Unit, Massachusetts General Hospital, Boston, MA 02114.
Diabetes 1992;41(8):927–935
Article history
Received:
February 12 1991
Revision Received:
March 27 1992
Accepted:
March 27 1992
PubMed:
1628767
Citation
Katina Chatzipanteli, Sheila Rudolph, Lloyd Axelrod; Coordinate Control of Lipolysis by Prostaglandin E2 and Prostacyclin in Rat Adipose Tissue. Diabetes 1 August 1992; 41 (8): 927–935. https://doi.org/10.2337/diab.41.8.927
Download citation file:
115
Views